Search Results
Onco
Daily
Twitter
Facebook
Youtube
RSS Feed
Linkedin
Facebook
RSS
X
Youtube
Linkedin
September, 2024
September 2024
M
T
W
T
F
S
S
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
« Aug
NCI center for cancer research
Jun 25, 2024, 13:41 |
Positive
Ruben Mesa: Raising over $4.5M for cancer research over the past 20 years
Ruben Mesa shared on LinkedIn: "Keep Pounding! Amazing event with over 1700 runners from Atrium…
Jun 25, 2024, 12:32 |
Blog
Jedd Wolchok shares his expert insights in cancer immunotherapy
Cancer Research Institute shared a post on LinkedIn: “What is immunotherapy, and how does it work?…
Jun 25, 2024, 09:36 |
Insight
Activating molecular target reverses multiple hallmarks of aging - MD Anderson Cancer Center
MD Anderson researchers identify molecule that reduces age-related inflammation and improves brain and muscle function…
Jun 25, 2024, 04:23 |
Insight
Post ASCO24 update on urothelial cancer by Benjamin Garmezy
Cathy Eng shared on X: "Benjamin Garmezy providing urothelial cancer with updated PRO data re:…
Jun 24, 2024, 22:56 |
Blog
Giovanni Marchegiani: Perioperative modified FOLFIRINOX for pancreas cancer
Giovanni Marchegiani, Pancreas Surgeon at The University of Padua, made the following post on X:…
Jun 24, 2024, 22:47 |
Blog
Cathy Eng: Very nice review of HER2 breast cancer update by Gregory Vidal
Cathy Eng shared a post on X: . “Very nice review of HER2 breast cancer…
Jun 24, 2024, 12:53 |
Blog
Cathy Eng: Activated at VUMC Cancer the Phase III at NCICTEP Clinical Research ERASur study for stage 4
Cathy Eng shared a post on X: “Activated today at Vanderbilt-Ingram Cancer Center Cancer the…
Jun 24, 2024, 10:17 |
Blog
Karen Knudsen: American Cancer Society and ACS CAN applaud Fifth Circuit's decision to protect access to preventive services
Karen Knudsen shared a post by American Cancer Society Cancer Action Network on LinkedIn: "The…
Jun 24, 2024, 04:49 |
Insight
New Paper Alert!- PARP Inhibitor Rucaparib Shows Promise in Metastatic Hormone-Sensitive Prostate Cancer with HRR Mutations
PARP Inhibitor Rucaparib Shows Promise in Metastatic Hormone-Sensitive Prostate Cancer with HRR Mutations Authors: Mark…
Jun 24, 2024, 03:46 |
Blog
Peter Pisters: MD Anderson Cancer Center's talented APPs in the Exploring, Development, Guiding, Engagement Program panel
Peter Pisters shared on X: "Pleased to join MD Anderson Cancer Center's talented APPs this…
32
33
34
35
36
All:
1754
Posts:
331 - 340
100 Influential Women in Oncology: Key Opinion Leaders to Follow on Social Media in 2024: Part 2
Running for a Cure: The Legacy of Terry Fox's Marathon of Hope
How The Breast Cancer Research Foundation was founded
Can Skin Cancer be Prevented by a $0.50 Soap? Meet TIME’s Kid of the Year and His Invention
100 Influential Women in Oncology: Key Opinion Leaders to Follow on Social Media in 2024
Special Coverage
ASCO Annual Meeting
May 30 - June 4, 2024
Yvonne Award 2024
May 31, 2024
OncoThon 2024, Online
Feb. 15, 2024
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Facebook
RSS Feed
X
Linkedin
Youtube